These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21545527)

  • 1. Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention.
    Baumann FT; Zopf EM; Nykamp E; Kraut L; Schüle K; Elter T; Fauser AA; Bloch W
    Eur J Haematol; 2011 Aug; 87(2):148-56. PubMed ID: 21545527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation.
    Laaksonen M; Ramseier AM; Rovó A; Jensen SB; Raber-Durlacher JE; Zitzmann NU; Waltimo T
    J Dent Res; 2011 Oct; 90(10):1177-82. PubMed ID: 21734227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of early rehabilitation on the duration of hospitalization in patients after allogeneic hematopoietic stem cell transplantation.
    Inoue J; Ono R; Okamura A; Matsui T; Takekoshi H; Miwa M; Kurosaka M; Saura R; Shimada T
    Transplant Proc; 2010 Sep; 42(7):2740-4. PubMed ID: 20832579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation.
    Wiskemann J; Huber G
    Bone Marrow Transplant; 2008 Feb; 41(4):321-9. PubMed ID: 18026154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
    Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of two conditioning regimens in treatment of leukemia by allogeneic hematopoietic stem cell transplantation].
    Zhang GC; Zheng D; Guan XX; Luo SK; Li J; Peng AH; Tong XZ; Lai FZ; Tan EX; Hong WD
    Ai Zheng; 2003 Jun; 22(6):620-3. PubMed ID: 12948413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).
    Safdar A; Singhal S; Mehta J
    Cancer; 2004 Jun; 100(11):2456-61. PubMed ID: 15160352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
    Danaher EH; Ferrans C; Verlen E; Ravandi F; van Besien K; Gelms J; Dieterle N
    Oncol Nurs Forum; 2006 May; 33(3):614-24. PubMed ID: 16676017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
    Zohren F; Czibere A; Bruns I; Fenk R; Schroeder T; Gräf T; Haas R; Kobbe G
    Bone Marrow Transplant; 2009 Dec; 44(12):785-92. PubMed ID: 19430496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
    Yanada M; Naoe T; Iida H; Sakamaki H; Sakura T; Kanamori H; Kodera Y; Okamoto S; Kanda Y; Sao H; Asai O; Nakai K; Maruta A; Kishi K; Furukawa T; Atsuta Y; Yamamoto K; Tanaka J; Takahashi S
    Bone Marrow Transplant; 2005 Nov; 36(10):867-72. PubMed ID: 16113659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation.
    Baumann FT; Kraut L; Schüle K; Bloch W; Fauser AA
    Bone Marrow Transplant; 2010 Feb; 45(2):355-62. PubMed ID: 19597418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience.
    Basara N; Roemer E; Kraut L; Guenzelmann S; Schmetzer B; Kiehl MG; Fauser AA
    Bone Marrow Transplant; 2002 Nov; 30(10):651-9. PubMed ID: 12420203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.